99 results
Page 2 of 5
8-K
EX-99.1
y5eij8e3 j0dp9
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
8-K
EX-99.1
ytfqm9ja
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm
8-K
EX-99.1
h6o34hpkuud
30 Mar 23
Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights
4:07pm
8-K
EX-99.1
3uoo367s
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
8-K
EX-99.1
425qg2yz8c63hbhzfp3
8 Nov 22
Completion of Acquisition or Disposition of Assets
8:40am
8-K
EX-99.1
81ndas0k5sl0fd1
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-99.2
fvbfiqpxtmez
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
phehlwu
11 Oct 22
Prospectus supplement with pricing info
8:27am
FWP
uqfp 3vqvune0c9
6 Oct 22
Free writing prospectus
4:05pm
8-K
EX-99.1
ofz6rxr23 32m
22 Sep 22
Material Modifications to Rights of Security Holders
4:32pm